Literature DB >> 2209252

Mesolimbic dopamine activation--the key to nicotine reinforcement?

P B Clarke1.   

Abstract

The mesolimbic dopaminergic system appears to mediate the rewarding effects of certain stimulant drugs, such as (+)amphetamine. Autoradiographic mapping techniques have revealed that these neurons are potential targets for nicotine, since they possess nicotinic receptors located on their cell bodies and terminals in rat brain. Functional studies are consistent with this proposal: nicotine can increase the firing rate of these neurons, and nicotine-induced dopamine release has been demonstrated in vitro and in vivo. The locomotor stimulant effect resulting from the acute administration of nicotine is accompanied by, and appears to be dependent upon, activation of mesolimbic neurons. Likewise, destruction of this system appears to attenuate the acute rewarding effects of intravenous nicotine in rats. Thus, when administered intermittently, nicotine, like certain other stimulant drugs, may activate the mesolimbic dopamine system, and this action may contribute to the tobacco habit.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2209252     DOI: 10.1002/9780470513965.ch9

Source DB:  PubMed          Journal:  Ciba Found Symp        ISSN: 0300-5208


  19 in total

1.  Correlation and predictive performances of saliva and plasma nicotine concentration on tobacco withdrawal-induced craving.

Authors:  Vincenzo Teneggi; Lisa Squassante; Laura Iavarone; Stefano Milleri; Alan Bye; Roberto Gomeni
Journal:  Br J Clin Pharmacol       Date:  2002-10       Impact factor: 4.335

2.  The selective dopamine D3 receptor antagonist SB-277011A reduces nicotine-enhanced brain reward and nicotine-paired environmental cue functions.

Authors:  Arlene C Pak; Charles R Ashby; Christian A Heidbreder; Maria Pilla; Jeremy Gilbert; Zheng-Xiong Xi; Eliot L Gardner
Journal:  Int J Neuropsychopharmacol       Date:  2006-08-31       Impact factor: 5.176

3.  Preferential increase of extracellular dopamine in the rat nucleus accumbens shell as compared to that in the core during acquisition and maintenance of intravenous nicotine self-administration.

Authors:  Daniele Lecca; Fabio Cacciapaglia; Valentina Valentini; Janne Gronli; Saturnino Spiga; Gaetano Di Chiara
Journal:  Psychopharmacology (Berl)       Date:  2006-01-06       Impact factor: 4.530

4.  A mouse model for chronic intermittent electronic cigarette exposure exhibits nicotine pharmacokinetics resembling human vapers.

Authors:  Xuesi M Shao; Briana Lopez; David Nathan; Julian Wilson; Emmanuel Bankole; Hayk Tumoyan; Alexandra Munoz; Jorge Espinoza-Derout; Kamrul M Hasan; Scarlett Chang; Christina Du; Amiya P Sinha-Hikim; Kabirullah Lutfy; Theodore C Friedman
Journal:  J Neurosci Methods       Date:  2019-07-27       Impact factor: 2.390

Review 5.  Nicotine-related brain disorders: the neurobiological basis of nicotine dependence.

Authors:  E L Ochoa
Journal:  Cell Mol Neurobiol       Date:  1994-06       Impact factor: 5.046

6.  Evidence of cross-tolerance between behavioural effects of nicotine and cocaine in mice.

Authors:  Rajeev I Desai; Philip Terry
Journal:  Psychopharmacology (Berl)       Date:  2003-01-24       Impact factor: 4.530

7.  Nicotinic and muscarinic components of rat brain dopamine synthesis stimulation induced by physostigmine.

Authors:  J Grenhoff; T H Svensson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-10       Impact factor: 3.000

Review 8.  Individual differences in sensitivity to nicotine: implications for genetic research on nicotine dependence.

Authors:  O F Pomerleau
Journal:  Behav Genet       Date:  1995-03       Impact factor: 2.805

9.  5HT3 receptor antagonists do not block nicotine induced hyperactivity in rats.

Authors:  B Arnold; K Allison; S Ivanová; P R Paetsch; T Paslawski; A J Greenshaw
Journal:  Psychopharmacology (Berl)       Date:  1995-05       Impact factor: 4.530

10.  Intravenous nicotine injection induces rapid, experience-dependent sensitization of glutamate release in the ventral tegmental area and nucleus accumbens.

Authors:  Magalie Lenoir; Eugene A Kiyatkin
Journal:  J Neurochem       Date:  2013-10-21       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.